Ondero 5 mg (Linagliptin)
| Active Ingredient | Linagliptin |
|---|---|
| Indication: | Type 2 diabetes |
| Manufacturer: | Boehringer Ingelheim-Lupin |
| Strength | 5mg |
| Packaging | 10 Tablets in 1 Strip |
Ondero 5 mg is an oral prescription medicine that contains Linagliptin, a powerful DPP-4 inhibitor used for managing type 2 diabetes mellitus. It works by increasing levels of natural substances called incretins, which help to control blood sugar by increasing insulin release, especially after meals.
This medicine is usually taken once daily and is often prescribed along with diet and exercise to improve glycemic control. Linagliptin in Ondero is known for its low risk of causing hypoglycemia and does not usually lead to weight gain, making it a preferred choice for many.
✅ Note: Ondero should be taken under medical supervision. It is not suitable for type 1 diabetes or diabetic ketoacidosis.








There are no reviews yet.